Ibogaine Treatment Portland, OR: Law, Cost, Clinics

Ibogaine Treatment Portland, Oregon: What Oregon Did and Did Not Legalise

If you have read that Oregon became the first state to legalise physician-supervised ibogaine, that is not what happened. A bill to do exactly that — House Bill 4110 — was introduced in February 2026, got a public hearing, and then died in the House Committee on Behavioral Health when the short session adjourned on 6 March 2026. It never received a vote in either chamber.

We are leading with the correction because Portland is the one city in America where people reasonably assume the law is further along than it is. Oregon does have a first-in-the-nation regulated psychedelic programme. It covers psilocybin. It does not cover ibogaine.

Psychedelic Connect is a treatment advisory service. We help Portland and Multnomah County patients understand what is actually available and, where ibogaine is appropriate, connect them with vetted, medically supervised clinics. Call (866) 435-7057 or request a consultation to speak with a patient coordinator.

Before planning anything, see what ibogaine treatment costs.

Can You Get Ibogaine Treatment in Portland?

No. Ibogaine is Schedule I under federal law, and Oregon has created no exemption for it. No licensed facility in Portland or anywhere in Oregon can administer ibogaine. Legal, medically supervised treatment means travelling abroad.

Oregon’s psilocybin service centres are licensed for psilocybin only. A service centre cannot legally offer you ibogaine, and one that offers to is operating outside its licence and outside the law.

What Happened to Oregon’s Ibogaine Bill, HB 4110?

It died in committee. The Oregon Legislature’s own record shows four actions, no votes, and no chapter number. The bill would have let an attending physician provide ibogaine to a patient and exempted it from the state definition of a controlled substance — but it never left the House Committee on Behavioral Health.

The complete legislative history, from the Legislature’s measure record:

• 2 February 2026 — first reading, referred to the Speaker’s desk.
• 2 February 2026 — referred to the House Committee on Behavioral Health.
• 10 February 2026 — public hearing held.
• 6 March 2026 — “In committee upon adjournment.”

That is the entire record. No work session, no committee vote, no floor vote, no chapter number assigned. In Oregon, a measure still sitting in committee when the session adjourns sine die is dead for that session.

We have seen the 10 February public hearing reported online as the date Oregon “passed” the bill. A hearing is not a vote. If a source told you Oregon legalised ibogaine in February 2026, that source cannot be relied on for anything else about your treatment either.

Source: Oregon Legislative Information System, HB 4110, 2026 Regular Session — measure overview and measure history. Accessed 12 September 2026.

Does Oregon’s Psilocybin Programme Cover Ibogaine?

No. Oregon’s regulated programme, created by Measure 109 and administered by the Oregon Health Authority, applies to psilocybin and nothing else. MDMA, LSD, DMT, ayahuasca and ibogaine all remain outside it.

This is the single most common misunderstanding we hear from Portland callers, and it is an understandable one. Oregon genuinely did something no other state had done — it built a licensed, regulated framework for supervised psilocybin sessions, open to adults without a prescription or diagnosis. It is reasonable to assume that framework grew to include other compounds. It did not.

The practical consequence: an Oregon facilitator licence, a service centre licence and the whole psilocybin regulatory apparatus give you no route to ibogaine. HB 4110 was the attempt to build a separate route, and it failed.

Is Ibogaine the Right Tool for Portland’s Drug Crisis?

For part of it. Oregon’s overdose deaths are overwhelmingly fentanyl, methamphetamine, or both together — and ibogaine’s evidence is about opioids. For the large share of Portland cases involving both drugs, it addresses one half of the problem.

The Oregon Health Authority reported in May 2026 that more than 90% of the state’s reported overdose deaths involved fentanyl, methamphetamine or some combination of both. In 2024, 62.2% of overdose deaths involved more than one substance, and about 70% of those polysubstance deaths involved fentanyl and methamphetamine together.

Multnomah County’s own fentanyl mortality report tracked the same shift locally: in 2018, 27% of local fentanyl overdose deaths involved another drug as well; by 2023 that had risen to 63%, with methamphetamine the most common companion.

What that means if you are deciding:

• Opioid dependence — fentanyl, heroin, prescription opioids, methadone and buprenorphine. This is where ibogaine’s published evidence sits, principally its ability to interrupt withdrawal. See ibogaine for opioid dependence.
• Methamphetamine — the evidence is considerably weaker, and there is no stimulant withdrawal syndrome for ibogaine to interrupt the way it interrupts opioid withdrawal. See ibogaine and methamphetamine.
• Both together — which describes most fatal overdoses in this county. Ibogaine may resolve the opioid half and leave the stimulant half largely untouched. A clinic that does not raise this with you before taking your money is not being straight.

We would rather tell a Portland family that ibogaine addresses part of their situation than accept an enquiry we cannot honestly serve.

Is Oregon’s Overdose Crisis Getting Better?

Yes, measurably, for the first time in years. Oregon recorded 1,544 overdose deaths in 2024, down from 1,833 in 2023 — the first year-over-year decline since 2016. Preliminary 2025 data pointed lower again.

We include this because it changes the advice, not because it softens the picture. Something in Oregon’s response — naloxone distribution, the fentanyl emergency response in Multnomah County, treatment expansion — is working. The state still recorded 4,193 overdose-related inpatient hospitalisations and 10,365 overdose-related emergency department visits in 2024, so the scale remains enormous. But a person in Portland weighing an expensive trip abroad for a Schedule I drug deserves to know that local services are improving rather than collapsing, and that exhausting them first is a reasonable step rather than a waste of time.

Sources: Oregon Health Authority, “Oregon overdose deaths declined in 2024, 2025,” 13 May 2026; Multnomah County Fentanyl Overdose Mortality Report, 14 May 2024.

What Happens Before You Travel?

Screening comes first. Ibogaine affects heart rhythm, so clinics require an ECG and bloodwork, a full medication review and a medical history before accepting anyone. Some people are screened out — and being told no is the system working.

• Initial conversation — what you are treating, what you have already tried, current medications and doses.
• Medical screening — ECG, liver and kidney panels, electrolytes. Some medications, particularly certain antidepressants and long-acting opioids, need a supervised taper arranged well beforehand.
• Clinic matching — facilities whose medical model fits the presentation, not whichever one has a bed free.
• Treatment — most programmes run seven to ten days.
• Integration — the part that decides whether the result holds. See integration therapy after ibogaine.

If you are in acute withdrawal or crisis right now, call 988 or 911. Ibogaine requires weeks of preparation and cannot be accessed on an emergency timeline.

Getting from Portland to a Mexican Clinic

Portland International connects to Mexico both directly on seasonal routes and through Los Angeles, San Francisco, Phoenix or Dallas. Baja California clinics near Tijuana and Rosarito are usually reached via a San Diego connection and are the shorter trip from the Pacific Northwest; Cancún holds the largest concentration of established ibogaine clinics and takes most of a day. Airline schedules shift seasonally, so we check current routing with you rather than printing a flight time that goes stale.

Travel time is the least important variable in this decision. Programme length, whether a physician is on site overnight, what screening is required before you fly, and whether integration is included matter far more to the outcome.

What Does Treatment Cost for Oregon Patients?

Between $5,000 and $15,000, depending on length of stay and facility. Insurance does not cover it, because ibogaine is Schedule I in the United States. Budget separately for flights and for integration support afterwards.

The range reflects real differences: programme length, whether a physician is on site around the clock, the level of cardiac monitoring, private versus shared accommodation, and whether integration is bundled. A price well below that range usually means fewer medical staff, which is the wrong place to economise on a drug with known cardiac risk.

For comparison, a supervised psilocybin session at an Oregon service centre is a different product at a different price for a different problem — it is not a cheaper version of ibogaine, and it is not indicated for opioid withdrawal.

What About Oregon Veterans?

Several clinics in our network run protocols built for combat-related PTSD, traumatic brain injury and co-occurring substance use. The VA cannot provide ibogaine — it is Schedule I, and no state law changes that.

The Portland VA Medical Center serves veterans across the region and can treat the conditions people often seek ibogaine for, through means that are legal here. If you are considering travelling, we would rather you go having tried what is available than instead of it. See ibogaine for veterans for how these protocols are structured and what the evidence does and does not show.

What Psychedelic Connect Does

We are a treatment advisory service, not a clinic. We do not administer ibogaine and we do not own a facility. We help you work out whether ibogaine is reasonable in your specific case, and if it is, which clinic fits.

We visit the clinics we recommend — we look at medical staffing, monitoring equipment, what happens overnight, and what a facility does when something goes wrong. We are guided by people who get it, including clinicians and people who have been through this themselves. Our clinical content is reviewed by Christopher Diviaio, LCSW. If you want to pressure-test any provider, including us, our guide on how to vet an ibogaine provider lists the questions worth asking.

Resources in Portland and Multnomah County:

• SAMHSA National Helpline: (800) 662-4357 — 24/7 treatment referral (samhsa.gov)
• 988 Suicide & Crisis Lifeline: call or text 988
• Veterans Crisis Line: 988, then Press 1
• Multnomah County Behavioral Health Call Center: (503) 988-4888 — 24/7 crisis and treatment referral

Consultation — Call Today

If you are in Portland, Gresham, Beaverton, Hillsboro, Vancouver or anywhere in the Portland metro, call (866) 435-7057 to talk with a patient coordinator. You can also start with our online form and we will follow up within one business day.

Medical Disclaimer: Psychedelic Connect is a treatment advisory service. We do not provide medical advice. Ibogaine treatment involves serious medical considerations including cardiac risks. Always consult a qualified medical professional before pursuing any treatment.

Frequently Asked Questions — Ibogaine Treatment, Portland and Oregon

Did Oregon legalise ibogaine?
No. House Bill 4110 would have allowed an attending physician to provide ibogaine and exempted it from Oregon’s controlled-substance definition, but it died in the House Committee on Behavioral Health when the 2026 session adjourned on 6 March 2026. The Legislature’s record shows a public hearing on 10 February 2026 and no votes at any stage. Ibogaine remains Schedule I in Oregon and federally.

Can an Oregon psilocybin service centre give me ibogaine?
No. Oregon’s regulated programme covers psilocybin only. A licensed service centre has no authority to administer ibogaine, MDMA, DMT, ayahuasca or any other psychedelic, and a centre offering ibogaine is operating outside both its licence and the law.

Will Oregon try again on ibogaine?
It may. A measure that dies in committee can be reintroduced in a later session, and HB 4110 got a public hearing rather than being ignored, which suggests some appetite. But nobody can tell you when, and any successor bill would still need committee approval, floor votes in both chambers and a signature before anything changed. Treat any specific date you are offered as speculation.

Does ibogaine work for methamphetamine addiction?
The evidence is much weaker than for opioids, which matters a great deal in Portland. The Oregon Health Authority reports that more than 90% of the state’s overdose deaths involve fentanyl, methamphetamine or both, and Multnomah County’s fentanyl deaths involving a second drug rose from 27% in 2018 to 63% in 2023. Ibogaine’s best-documented effect is interrupting opioid withdrawal; there is no equivalent stimulant withdrawal for it to interrupt.

Are overdose deaths in Oregon falling?
Yes. Oregon recorded 1,544 overdose deaths in 2024, down from 1,833 in 2023 — the first year-over-year decline since 2016 — with preliminary 2025 figures pointing lower again. The state still recorded 4,193 overdose-related hospitalisations and 10,365 emergency department visits in 2024.

How dangerous is ibogaine?
It carries real cardiac risk, which is why legitimate clinics require an ECG and bloodwork beforehand and why a facility without a physician on site should be ruled out. The published evidence for opioid dependence is promising but limited — mostly observational studies with small numbers and no control group. Anyone telling you the risk is negligible, or that the evidence is settled, is overselling it.

Psychedelic Connect · (866) 435-7057 · contact@psychedelic-connect.com

Published 12 September 2026 · Last updated 12 September 2026 · Clinical review: Christopher Diviaio, LCSW